Impactful collaborations with distinguished industry experts help drive the strategic direction of our company.
Chair, FHI Foundation | Former Chairman and Chief Executive Officer, FHI 360
U.S.A (Headquarters)
359 Blackwell Street, Suite 200, Durham, NC 27701 USA
South Africa
121 Amkor Road, Lyttelton Manor, Centurion, 0157, SOUTH AFRICA
Kenya
Britam Towers, 24th Floor, Hospital Road, Upper Hill KENYA
Liberia
The Cape Hotel, Mamba Point, Monrovia LIBERIA
Former Chairman, Board of Directors, FHI 360
With more than three decades of experience both as an active member of the angel investment community and in research and development, Edward Whitehorne brings a diverse blend of financial acumen, investment experience and technical expertise to the FHI Clinical Board of Directors.
An experienced investor with in-depth expertise in informatics, research and development, Mr. Whitehorne joined the FHI 360 Board of Directors in 2000, served as Vice Chair and became Chair in 2014, before retiring from the FHI Board in 2018. Mr. Whitehorne also previously served as Chair of FHI 360’s Executive Committee. He was a founder of Clinical Research International and a founding member of the Atlantis Group and TriState Investment Groups II, III and IV and served on their executive committees.
From 1999 to 2013, Mr. Whitehorne was a member of the Board of Directors of Novella Clinical, Inc., a leader in oncology and medical device clinical trials. In 2013, he led the sale of Novella to Quintiles, Inc. He also serves as a trustee of the FHI Foundation and chairs its investment committee.
Dr. Tessie San Martin brings extensive experience in both human development and humanitarian response to the role of Chief Executive Officer of FHI 360. A vocal advocate for gender equality, she has dedicated her career to creating a better and more just world for people everywhere.
Prior to joining FHI 360, San Martin was CEO and President of Plan International USA, an international development and humanitarian organization that partners with adolescent girls and children around the world to overcome oppression and gender inequality.
Previously, San Martin served as group vice president at Abt Associates, a consulting company providing research and technical assistance expertise on a wide range of social and economic policy issues, and as director for the Operations Group of the World Bank’s Multilateral Investment Guarantee Agency (MIGA).
She has more than 30 years of experience working as an executive in the public and private sectors, bilateral and multilateral development agencies and academia, focusing especially on economic growth and political reform. She has been a forceful advocate for aid effectiveness, serving as co-chair of the Modernizing Foreign Assistance Network (MFAN) and a board member of Friends of Publish What You Fund, which supports greater aid transparency, and InterAction, which convenes U.S.-based nongovernmental organizations working to eliminate extreme poverty and strengthen human rights and citizen participation.
San Martin has been published in media such as The New York Times and The Washington Post. She has a doctorate in political economy and government from Harvard University, a master’s degree in public administration from the John F. Kennedy School of Government at Harvard University and a bachelor’s degree from Georgetown University’s School of Foreign Service.
Consultant
Greg Connors served as Senior Vice President, Corporate Development at Quintiles during a 24-year career there. He has a track record of more than 30 years of driving corporate growth through merger, acquisition, divestiture and capital markets strategies and transactions. Prior to joining Quintiles, Mr. Connors served as a Senior Manager at EY, an Associate at Chemical Bank and an engineer at IBM. He holds a bachelor’s degree in Mechanical Engineering from Pennsylvania State University and a master’s degree in Business Administration from the University of Chicago.
Chair, FHI Foundation | Former Chairman and Chief Executive Officer, FHI 360
In addition to serving on the FHI Clinical Board of Directors, Albert J. Siemens, PhD has served on the FHI Foundation’s Board of Trustees since May of 2014 and was elected as its Chair in November 2014. He joined FHI 360 in 1983 with responsibility for the organization’s Clinical Trials Division. In 1998, Dr. Siemens was appointed Chief Executive Officer, a position he held until retirement on May 1, 2014.
In 1986, as Vice President of Research, Siemens was instrumental in the formation of Clinical Research International (CRI), an affiliate of FHI 360 that provided research services to pharmaceutical, biotechnology and medical device companies. He was President of CRI until the company was acquired by ClinTrials Research in late 1990. As Executive Vice President of ClinTrials Research from 1991 through 1997, he was responsible for international corporate expansion and business development. He was elected to the Board of Directors of FHI 360 in 1997 and as Chair of the Board in 2006. He was also CEO of PharmaLinkFHI (renamed Novella Clinical) from 1999 until 2008 and, thereafter, Chairman of the Board until 2013, when the company was acquired by Quintiles, Inc.
Dr. Siemens’ career in medicinal product development began at Pfizer, Inc., where he was responsible for clinical studies of cardiovascular, antibiotic, anti-inflammatory and psychotropic agents in domestic and international divisions of the company.
Dr. Siemens holds BSc (Pharmacy) and MS degrees from the University of Manitoba, and a PhD in Pharmacology from the University of Toronto. He is a member of the American Society of Clinical Pharmacology and other professional associations and has published on a range of subjects including the drug development process, drug metabolism, drug interactions, drug tolerance, membrane pharmacology and contraceptive evaluation.
